Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    Open Studies | "lung transplantation"
Show Display Options
Rank Status Study
21 Not yet recruiting VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation
Condition: End Stage Chronic Obstructive Airways Disease
Intervention:
22 Not yet recruiting Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation
Conditions: Cystic Fibrosis;   Lungtransplantation;   Paranasal Sinus Diseases
Intervention: Other: Bronchoalveolar and Nasal Lavage
23 Not yet recruiting Study to Evaluate the Value of the Follow-up of CALCIneurin Activity to MOdulate Calcineurin Inhibitors-induced Immunosuppression in Lung Transplantation
Condition: Lung Diseases
Interventions: Biological: levels of CNI in whole blood;   Biological: Calcineurin activity (CN-a) in peripheral blood mononuclear cells (PBMCs)
24 Recruiting Preliminary Study of Dornase Alpha to Treat Chest Infections Post Lung Transplant.
Conditions: Lung Transplant Infection;   Lower Respiratory Tract Infection.
Interventions: Drug: Dornase Alpha;   Drug: Isotonic Saline.
25 Recruiting Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Drug: Presatovir;   Drug: Placebo
26 Recruiting Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Constructive Bronchiolitis;   Graft Versus Host Disease
Intervention: Drug: Inhaled Cyclosporine Solution
27 Recruiting Microparticles and Bronchiolitis Obliterans Syndrome
Condition: Bronchiolitis Obliterans
Intervention: Other: Dosage of Microparticles (MPs) in broncho-alveolar lavage fluid (BALF)
28 Not yet recruiting DNA-based Testing in BAL of Lung Transplant Recipients With Suspected Non-viral Lower Respiratory Tract Infection
Condition: Lower Respiratory Tract and Lung Infections
Intervention: Other: Experimental Intervention: DNA-based testing of BAL fluid
29 Recruiting Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients
Conditions: Transplantation, Heart-Lung;   Chronic Lung Allograft Dysfunction;   Bronchiolitis Obliterans Syndrome
Interventions: Other: EIT;   Other: Salbutamol nebulisation and with CPAP
30 Recruiting Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3
Conditions: Bronchiolitis Obliterans;   Sleep Disordered Breathing Central
Intervention: Procedure: Assessment of sleep disorders and treatment if required
31 Not yet recruiting Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients
Condition: Lung Transplant Infection
Interventions: Drug: Inhaled beclomethasone;   Drug: Placebo
32 Recruiting Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Graft vs Host Disease
Intervention: Drug: Cyclosporine Inhalation Solution
33 Recruiting Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Conditions: Severe Combined Immunodeficiency (SCID);   Immunodeficiency With Predominant T-cell Defect, Unspecified;   Severe Chronic Neutropenia;   Chronic Granulomatous Disease (CGD);   Hyper IgE Syndromes;   Hyper IgM Deficiencies;   Wiskott-Aldrich Syndrome;   Mendelian Susceptibility to Mycobacterial Disease;   Common Variable Immune Deficiency (CVID)
Intervention: Biological: CD3/CD19 negative allogeneic hematopoietic stem cells
34 Recruiting Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
Conditions: Influenza, Human;   Transplantation Infection
Interventions: Biological: influenza trivalent inactive vaccine;   Biological: influenza trivalent inactive vaccine high dose
35 Recruiting Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction
Condition: Primary Graft Dysfunction
Intervention: Drug: Sodium Nitrite
36 Recruiting CLAD Phenotype Specific Risk Factors and Mechanisms.
Condition: Lung Transplant
Interventions: Procedure: Blood Draw;   Procedure: Bronchoscopy
37 Recruiting Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
Condition: Lung Transplant
Intervention: Device: Ex vivo lung perfusion with Steen Solution™
38 Recruiting Clinical Study Evaluating Two Treatment Protocols for Immunosuppresive Drugs. Looking at 3-year Incidence of CLAD.
Conditions: Lung Transplantation;   Allografts
Interventions: Drug: Cyclosporine;   Drug: Mycophenolate mofetil (MMF);   Drug: Rabbit Anti thymocyte globuline;   Drug: Corticosteroids;   Drug: Tacrolimus
39 Recruiting Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation, a Multicenter Study
Condition: Lung Transplant Rejection
Intervention:
40 Recruiting Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
Conditions: Primary Graft Dysfunction;   Lung Transplantation
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.